Aimed Alliance Submits Comment on 2025 NBPP
On January 8, 2024, Aimed Alliance submitted a comment to the Centers for Medicare and…
Author Aimed Alliance
Why Congress and the FDA Must Regulate CBD Consumer Products Now
On January 3, 2024, CareTalk published an opinion piece authored by Michael C. Barnes, Counsel…
CBO Responds to Calls from the House Budget Committee to Consider New Data on IRA Impact on Innovation
Responding to inquiries from the House Budget Committee, the Congressional Budget Office (CBO) has signaled…
Governor Hochul Signs Bill to Improve Consumer Information
Governor Hochul has signed A.463A/S.2677! Next year plans will be required to include in an…
DC Court Clarifies 2020 NBPP Is Current Law
On December 22, 2023, the US District Court for the District of Columbia issued an…
Urgent Calls for Federal Oversight of Hemp-Derived Cannabinoids Amid Rising Child Hospitalizations
In a recent article, the Wall Street Journal highlights how hundreds of children are being…
House Budget Committee Questions CBO’s Analysis of the IRA’s Impact on Drug Development
On November 20, 2023, the House Budget Committee addressed a letter to the Congressional Budget…
Know Your Rights Limited Formularies
On December 15, 2023 Aimed Alliance published a new resource titled Know Your Rights: Limited…
From Farm Bill to FDA: The Legal Landscape of CBD
In this CareTalk episode, host David Williams discusses the legal landscape of CBD with Michael…
Aimed Alliance Urges CMS to Protect Medicare Advantage Consumers From Double-Step Fail-First Policies
On December 13, 2023, Aimed Alliance sent a letter to CMS urging it to place…